The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
Identifieur interne : 000218 ( Main/Exploration ); précédent : 000217; suivant : 000219The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
Auteurs : N A Uvais [Inde]Source :
- The primary care companion for CNS disorders [ 2155-7780 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Hydroxychloroquine, Infections à coronavirus, Pneumopathie virale, Schizophrénie.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- Humains, Pandémies.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Hydroxychloroquine.
- complications : Coronavirus Infections, Pneumonia, Viral, Schizophrenia.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, Contraindications, Drug, Humans, Pandemics.
DOI: 10.4088/PCC.20com02635
PubMed: 32369686
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.</title><author><name sortKey="Uvais, N A" sort="Uvais, N A" uniqKey="Uvais N" first="N A" last="Uvais">N A Uvais</name><affiliation wicri:level="1"><nlm:affiliation>Iqraa International Hospital and Research Centre, Calicut, Kerala, India. druvaisna@gmail.com.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Iqraa International Hospital and Research Centre, Calicut, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32369686</idno><idno type="pmid">32369686</idno><idno type="doi">10.4088/PCC.20com02635</idno><idno type="wicri:Area/Main/Corpus">000A79</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A79</idno><idno type="wicri:Area/Main/Curation">000A79</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A79</idno><idno type="wicri:Area/Main/Exploration">000A79</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.</title><author><name sortKey="Uvais, N A" sort="Uvais, N A" uniqKey="Uvais N" first="N A" last="Uvais">N A Uvais</name><affiliation wicri:level="1"><nlm:affiliation>Iqraa International Hospital and Research Centre, Calicut, Kerala, India. druvaisna@gmail.com.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Iqraa International Hospital and Research Centre, Calicut, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala</wicri:regionArea><wicri:noRegion>Kerala</wicri:noRegion></affiliation></author></analytic><series><title level="j">The primary care companion for CNS disorders</title><idno type="eISSN">2155-7780</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus</term><term>Contraindications, Drug</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (drug therapy)</term><term>Humans</term><term>Hydroxychloroquine (adverse effects)</term><term>Pandemics</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (drug therapy)</term><term>Schizophrenia (complications)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term><term>Hydroxychloroquine (effets indésirables)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Pandémies</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Schizophrénie (complications)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Schizophrenia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Hydroxychloroquine</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Schizophrénie</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Contraindications, Drug</term><term>Humans</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pandémies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32369686</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2155-7780</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>04</Month><Day>30</Day></PubDate></JournalIssue><Title>The primary care companion for CNS disorders</Title><ISOAbbreviation>Prim Care Companion CNS Disord</ISOAbbreviation></Journal><ArticleTitle>The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.4088/PCC.20com02635</ELocationID><ELocationID EIdType="pii" ValidYN="Y">20com02635</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uvais</LastName><ForeName>N A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Iqraa International Hospital and Research Centre, Calicut, Kerala, India. druvaisna@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prim Care Companion CNS Disord</MedlineTA><NlmUniqueID>101547532</NlmUniqueID><ISSNLinking>2155-7780</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075203" MajorTopicYN="N">Contraindications, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32369686</ArticleId><ArticleId IdType="doi">10.4088/PCC.20com02635</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Uvais, N A" sort="Uvais, N A" uniqKey="Uvais N" first="N A" last="Uvais">N A Uvais</name></noRegion><name sortKey="Uvais, N A" sort="Uvais, N A" uniqKey="Uvais N" first="N A" last="Uvais">N A Uvais</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000218 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000218 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidPsychoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32369686
|texte= The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32369686" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPsychoV1
| This area was generated with Dilib version V0.6.35. |  |